Aarti Drugs Limited intimates exchanges of its upcoming Board meeting on May 15, 2026.
The Board will consider and approve audited financial results for Q4 and FY ended March 31, 2026.
The company's trading window remains closed until 48 hours after results declaration.
This intimation is made pursuant to SEBI Listing Regulations, Regulation 29.